According to the current analysis
of Reports and Data, the global structural
biology and molecular modeling market was valued at USD 4.00 billion
in 2018 and is expected to reach USD 14.97 billion by the year 2026, at a CAGR
of 17.9%. The global structural biology and molecular modeling market is an
essential part of the worldwide healthcare sector and has already made vital
contributions in obtaining remedies to several diseases. The structural biology
and molecular modeling field are concerned with an arrangement of various
molecules in biological compounds and how the peculiarity of the arrangement
affects the nature of the compound. The field also shows different alterations
in the structure of the compounds affecting their environment and showing the
position of each part of the structure, which is linked to the overall nature
of the compound.
Improving the quality of medicine
and healthcare, in general, has been a key focus of governments across the
world in recent years due to the rising volume of patient demographics and the
growing geriatric population. This has driven consistent investment in medical
research in recent years, making steady development of the structural biology
and molecular modeling techniques market likely in the future. Rising drug
resistance coupled with high drug attrition rate is engendering the requirement
for extensive R&D activities, which is presumed to boost the adoption of
structural biology & molecular modeling techniques in the drug discovery
and development process. The high cost of equipment may hamper the market
growth.
Further key findings from
the report suggest
- Researchers of the University of Natural Resources
and Life Sciences in Austria proceed out molecular dynamics simulations to
study the activity of humanized antibodies (Ab2/3H6), which is believed to
neutralize HIV-1.
- Large drug attrition rate associated with late-phase
clinical trials in drug development is a significant contributor of the
elevated costs, which is further presumed to propel the demand for
modeling techniques to reduce the probability of drug failure.
- Potency determination of a new drug molecule in the
silicon screening of 3-D chemical structures expedite the lead discovery
and optimization process, thereby allowing the greater focus to be laid on
targets with high therapeutic potential.
- North America captured a dominant share in the overall
structural biology & molecular modeling techniques market with 35%.
Heightening their R&D capabilities to ensure high medical standards is
expected to propel the demand in this region.
- Threading is valued at 883.9 million in 2018 and
expected to reach 3.23 billion in 2026 by increasing technological
advancements in threading segment.
- Molecular dynamics is the fastest-growing segment
with CAGr of 17.7% and expected to reach 2.61 billion in 2026.
- Stringent regulation by government and availability
of alternatives is one of the restraints to this market growth.
- The key market players for this market include
AlDassault Systemes, Agile Molecule, Accellera Ltd., Bioinformatic LLC,
Affymetrix, Agilent Technologies, Inc., Illumina, Bruker Daltonics Inc.,
Biomax Informatics AG, Chemical Computing Group, and CLC bio
To identify the key trends in
the industry, click on the link below:
No comments:
Post a Comment